Alterations of lipid metabolism in Wilson disease
详细信息 查看全文
- 作者：Jessica Seessle (1)
Annina Gohdes (1)
Daniel Nils Gotthardt (1)
Jan Pfeiffenberger (1)
Nicola Eckert (1)
Wolfgang Stremmel (1)
Ulrike Reuner (2)
Karl Heinz Weiss (1) - 关键词：Wilson Disease ; lipids ; cholesterol ; triglycerides ; liver disease
- 刊名：Lipids in Health and Disease
- 出版年：2011
- 出版时间：December 2011
- 年：2011
- 卷：10
- 期：1
- 全文大小：246KB
- 参考文献：1. Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML: Wilson's disease. / Lancet 2007,396(9559):397鈥?08. CrossRef
2. Ferenci P: Pathophysiology and clinical features of Wilson disease. / Metab Brain Dis 2004,19(3鈥?):229鈥?39. CrossRef
3. Thomas GR, Forbes JR, Roberts EA, Walshe JM, Cox DW: The Wilson disease gene: spectrum of mutations and their consequences. / Nat Genet 1995,9(2):210鈥?17. CrossRef
4. Cox DW, Moore SD: Cooper transporting P-type ATPases and human diseases. / J Bioenerg Biomemb 2002,34(5):333鈥?38. CrossRef
5. Ferenci P: Regional distribution of mutations of the ATB7B gene in patients with Wilson disease: impact on genetic testing. / Hum Genet 2006,120(2):151鈥?59. CrossRef
6. Stremmel W, Meyerrose KW, Niederau C, Hefter H, Kreuzpaintner G, Strohmeyer G: Wilson disease: clinical presentation, treatment and survival. / Ann Intern Med 1991,115(9):720鈥?26.
7. Huster D: Wilson disease. / Best Pract Res Clin Gastroenterol 2010,24(5):531鈥?39. CrossRef
8. Ferenci P, Czlonkowska A, Merle U, Ference S, Gromadzka G, Yurdaydin C, Vogel W, Bruha R, Schmidt HT, Stremmel W: Late-onset Wilson's disease. / Gastroenterology 2007,132(4):1294鈥?298. CrossRef
9. Vergani C, Trovato G, Del霉 A, Pietrogrande M, Dioguardi N: Serum total lipids, lipoprotein cholesterol, and apolipoprotein A in acute virale hepatitis and chronic liver disease. / J Clin Pathol 1978,31(8):772鈥?78. CrossRef
10. Huster D, Purnat TD, Burkhead JL, Ralle M, Fiehn O, Stuckert F, Olson NE, Teupser D, Lutsenko S: High copper selectively alters lipid metabolism and cell cycle machinery in the mouse model of wilson disease. / J Biol Chem 2007,282(11):8343鈥?355. CrossRef
11. Levy E, Brunet S, Alvarez F, Seidman E, Bouchard G, Escobar E, Martin S: Abnormal hepatobiliary and circulating lipid metabolism in the Long-Evans Cinnamon rat model of Wilson's disease. / Life Science 2007,80(16):1472鈥?483. CrossRef
12. Yount QN, McNamara DJ, Al-Othman AA, Lei KY: The effect of copper deficiency on rat hepatic 3-hydroxy-3-methylglutaryl coenzym A reductase activity. / J Nut Biochem 1990,1(1):21鈥?7. CrossRef
13. Huster D, Lutsenko S: Wilson disease: not just a cooper disorder. Analysis of Wilson disease model demonstrates the link between cooper and lipid metabolism. / Mol Bio Syst 2007,3(1):816鈥?24. CrossRef
14. Galhardi CM, Diniz YS, Rodrigues HG, Faine LA, Burneiko RC, Ribas BO, Novelli EL: Benefical effects of dietary copper supplementation on serum lipids and antioxidant defenses in rats. / Ann Nutr Metab 2005,49(5):283鈥?88. CrossRef
15. Brewer JG, Yuzbasiyan-Gurkan V, Johnson V: Treatment of Wilson's disease with zinc IX: Response of serum lipids. / J Lab Clin Med 1991,118(5):466鈥?70.
16. Rodo M, Czonkowska A, Pulawska M, Swiderska M, Tarnacka B, Wehr H: The level of serum lipid, vitamin E and low density lipoprotein oxidation in Wilson's disease patients. / Europ J Neurol 2007, 7:491鈥?94. CrossRef
17. Hooper PL, Visconti L, Garry PJ, Johnson GE: Zinc lowers high-density lipoprotein-cholesterol levels. / Jama 1980,244(17):1960鈥?961. CrossRef
18. Chandra RK: Excessive intake of zinc impairs immune responses. / Jama 1984,252(11):1443鈥?446. CrossRef
19. Black MR, Medeiros D, Brunett E, Welke R: Zinc supplements and serum lipids in young adult white males. / Am J Clin Nutr 1988,47(6):970鈥?75.
20. Ferenci P, Caca K, Loudianos G, Mieli-Vergani G, Tanner S, Sternlieb I, Schilsky M, Cox D, Berr F: Diagnosis and phenotypic classification of Wilson disease. / Liver Int 2003,23(3):139鈥?42. CrossRef
21. Weiss KH, Gotthardt DN, Klemm D, Merle U, Ferenci-Foerster D, Schaefer M, Ferenci P, Stremmel W: Zinc Monotherapy is not as effective as chelating agents in treatment of Wilson disease. / Gastroenterology 2011,140(4):1189鈥?198. CrossRef - 作者单位：Jessica Seessle (1)
Annina Gohdes (1)
Daniel Nils Gotthardt (1)
Jan Pfeiffenberger (1)
Nicola Eckert (1)
Wolfgang Stremmel (1)
Ulrike Reuner (2)
Karl Heinz Weiss (1)
1. Department of Gastroenterology, University Hospital Heidelberg, Heidelberg, Germany
2. Department of Neurology, University Hospital Dresden, Dresden, Germany
文摘
Introduction Wilson disease (WD) is an inherited disorder of human copper metabolism, characterised by accumulation of copper predominantly in the liver and brain, leading to severe hepatic and neurological disease. Interesting findings in animal models of WD (Atp7b-/- and LEC rats) showed altered lipid metabolism with a decrease in the amount of triglycerides and cholesterol in the serum. However, serum lipid profile has not been investigated in large human WD patient cohorts to date. Patients and Methods This cohort study involved 251 patients examined at the Heidelberg and Dresden (Germany) University Hospitals. Patients were analysed on routine follow-up examinations for serum lipid profile, including triglycerides, cholesterol, high density lipoprotein (HDL) and low density lipoprotein (LDL). Data on these parameters at time of diagnosis were retrieved by chart review where available. For statistical testing, patients were subgrouped by sex, manifestation (hepatic, neurological, mixed and asymptomatic) and treatment (D-penicillamine, trientine, zinc or combination). Results A significant difference in total serum cholesterol was found in patients with hepatic symptoms, which diminished under therapy. No alterations were observed for HDL, LDL and triglycerides. Conclusion Contradictory to previous reports using WD animal models (Atp7b-/- and LEC rats), the most obvious alteration in our cohort was a lower serum cholesterol level in hepatic-affected patients, which might be related to liver injury. Our data suggested unimpaired cholesterol metabolism in Wilson disease under therapy, independent of the applied medical treatment.